Trial site
Fondazione Istituto G. Giglio Di Cafalu
- 13running trials
- 7closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis10 trials
- Alzheimer disease9 trials
- Mild cognitive impairment2 trials
- Myasthenia gravis1 trial
- Phase
- Phase 310 trials
- Phase 29 trials
- Phase 2/31 trial
- Status
- Active, not recruiting8 trials
- Completed7 trials
- Recruiting4 trials
- Not yet recruiting1 trial
- Lead sponsor
- Hoffmann-La Roche3 trials
- ACADIA Pharmaceuticals Inc.2 trials
- Biogen2 trials
- Glaxosmithkline Research & Development Limited2 trials
- Zenas BioPharma (USA), LLC2 trials
- and 9 more
Running trials
Recruiting
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
Active, not recruiting
Study of an On-Body Injection System for Home Use of Ocrelizumab in People with Multiple Sclerosis
Recruiting
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Recruiting
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Recruiting
Recruiting
A Phase 2 Study of Obexelimab in Patients with Relapsing Multiple Sclerosis
Active, not recruiting
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Enrolling by invitation
ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease3 recruiting
- Multiple sclerosis2 recruiting
Closed trials
Completed
A clinical trial to learn about the effects of VHB937 in people with Alzheimer's disease
Completed
GSK4527226 Open-label Extension Study in Patients with Early Alzheimer's Disease.
Recruiting
Completed
EFFICACY AND SAFETY OF GSK4527226 [AL101] IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE
Terminated
A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis
Recruiting
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026